A Membrane-Associated DHH-DHHA1 Nuclease Degrades Type III CRISPR Second Messenger.
CRISPR ribonuclease deactivation
DHH-DHHA1 nuclease
Sulfolobu
Type III CRISPR system
cyclic oligo-adenylate
membrane association
second messenger signaling
Journal
Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691
Informations de publication
Date de publication:
15 09 2020
15 09 2020
Historique:
received:
26
02
2020
revised:
21
07
2020
accepted:
20
08
2020
entrez:
16
9
2020
pubmed:
17
9
2020
medline:
5
5
2021
Statut:
ppublish
Résumé
Type III CRISPR-Cas systems initiate an intracellular signaling pathway to confer immunity. The signaling pathway includes synthesis of cyclic oligo-adenylate (cOA) and activation of the RNase activity of type III accessory ribonuclease Csm6/Csx1 by cOA. After the immune response, cOA should be cleared on time to avoid constant cellular RNA degradation. In this study, we find a metal-dependent cOA degradation activity in Sulfolobus islandicus. The activity is associated with the cell membrane and able to accelerate cOA clearance at a high cOA level. Further, we show that a metal-dependent and membrane-associated DHH-DHHA1 family nuclease (MAD) rapidly cleaves cOA and deactivates Csx1 ribonuclease. The cOA degradation efficiency of MAD is much higher than the cellular ring nuclease. However, the subcellular organization may prevent it from degrading nascent cOA. Together, the data suggest that MAD acts as the second cOA degrader after the ring nuclease to remove diffused redundant cOA.
Identifiants
pubmed: 32937129
pii: S2211-1247(20)31122-0
doi: 10.1016/j.celrep.2020.108133
pii:
doi:
Substances chimiques
Adenine Nucleotides
0
Archaeal Proteins
0
Metals
0
Oligoribonucleotides
0
2',5'-oligoadenylate
61172-40-5
Endonucleases
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
108133Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Interests The authors declare no competing interests.